Potential Dilution from the Exercise of Stock Acquisition Rights
First written in FY2021. 5 of 11 entries say "Worsened", first in FY2023-Q1. Latest entry: FY2026.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026WorsenedAnnual report
「As of the end of the fiscal year, the number of potential shares associated with the share acquisition rights issued by the company was 2,145,900, representing 12.6% of the 16,999,600 issued shares. If the share acquisition rights are exercised, the value per share of the company's stock may be diluted.」
The proportion of potential shares rose from 4.9% in the previous fiscal year to 12.6% due to the remaining portion and other matters related to the 29th series of share acquisition rights. The issuance of 2,250,100 shares through the exercise of the 29th series of share acquisition rights also actually occurred. - FY2025MitigatedAnnual report
「As of the end of the fiscal year, the number of potential shares associated with the share acquisition rights issued by the company was 716,000, representing 4.9% of the 14,759,500 issued shares.」
The exercise of the 28th series of share acquisition rights has been completed on a cumulative basis, leaving 716,000 potential shares, or 4.9%, and reducing the potential dilution from 16.5% in the previous fiscal year. - FY2025-H1MaterialisedAnnual report
「Between 1 April 2024 and 30 September 2024, the exercise of share acquisition rights increased the number of issued shares by 2,804,100 and share capital and the capital reserve by ¥465.129 million each.」
The exercise of the 28th series of share acquisition rights resulted in the issuance of 2,804,100 shares and an increase in the number of issued shares, showing that dilution from the exercise of share acquisition rights actually occurred. - FY2024WorsenedAnnual report
「As of the end of the month preceding the month in which this document was filed, the number of potential shares associated with share acquisition rights, including stock options, was 2,194,400, representing 16.5% of the 13,279,100 issued shares. If these share acquisition rights are exercised, the value per share of the company's stock may be diluted.」
The proportion of potential shares rose from 7.2% in the previous fiscal year to 16.5% due to the issuance and other matters related to the 28th series of share acquisition rights. During the fiscal year, 106,400 shares were delivered in connection with the 28th series of share acquisition rights, increasing the potential dilution. - FY2024-Q3MaterialisedAnnual report
「The exercise of share acquisition rights increased the number of issued shares by 70,600 to 11,830,000 as of the end of the third-quarter accounting period.」
The exercise of share acquisition rights resulted in the issuance of 70,600 new shares and an increase in the number of issued shares, showing that dilution from the exercise of share acquisition rights actually occurred. - FY2023WorsenedAnnual report
「As of the end of the fiscal year, the number of potential shares associated with the share acquisition rights issued by the company was 844,100, representing 7.2% of the 11,759,400 issued shares.」
The proportion of potential shares rose from 4.0% in the previous fiscal year to 7.2%, increasing the potential dilution from the share acquisition rights. - FY2023-Q1WorsenedAnnual report
「At the ordinary general meeting of shareholders and the Board of Directors meeting held on 23 June 2022, the company resolved, pursuant to Articles 236, 238 and 239 of the Companies Act, to issue share acquisition rights as stock options to its directors, including directors who are Audit and Supervisory Committee members, executive officers and employees, and issued them on 11 July 2022.」
On 11 July 2022, after the quarter-end, the company issued the 27th series of share acquisition rights, covering 369,000 common shares, to directors, executive officers and employees. - FY2022MitigatedAnnual report
「As of the end of the fiscal year, the number of potential shares associated with the share acquisition rights issued by the company was 475,100, representing 4.0% of the 11,759,400 issued shares.」
The proportion of potential shares fell from 10.0% in the previous fiscal year to 4.0%, reducing the potential dilution risk. - FY2021First statedAnnual report
「As of the end of the fiscal year, the number of potential shares associated with the share acquisition rights issued by the company was 838,600, representing 10.0% of the 8,386,400 issued shares.」
The company has granted stock options to its officers and employees and describes the potential dilution if they are exercised in the future.